122 related articles for article (PubMed ID: 16294913)
1. Impact of dose and volume on the tolerance of central nervous system.
Balducci M; Mattiucci GC; Dinapoli N; Bavasso A; de Renzi F; Marazzi F; Maronta D; Deodato F
Rays; 2005; 30(2):189-95. PubMed ID: 16294913
[TBL] [Abstract][Full Text] [Related]
2. Impact of dose and volume on rectal tolerance.
Gambacorta MA; Manfrida S; D'Agostino G; Digesù C; D'Onofrio I; Rosato H; Valentini V
Rays; 2005; 30(2):181-7. PubMed ID: 16294912
[TBL] [Abstract][Full Text] [Related]
3. Impact of dose and volume on subcutaneous fibrosis.
De Santis M; Luzi S; Errico A; Frascino V; Mangiacotti MG; Picardi V; Morganti AG
Rays; 2005; 30(2):169-73. PubMed ID: 16294910
[TBL] [Abstract][Full Text] [Related]
4. TCP and NTCP: a basic introduction.
Baumann M; Petersen C
Rays; 2005; 30(2):99-104. PubMed ID: 16294901
[TBL] [Abstract][Full Text] [Related]
5. Dose and volume as predictive factors of pulmonary toxicity.
Trodella L; Ramella S; Salvi G; Arcangeli S; Ciresa M; Massaccesi M; Macchia G; D'Angelillo RM
Rays; 2005; 30(2):175-80. PubMed ID: 16294911
[TBL] [Abstract][Full Text] [Related]
6. Impact of dose and volume on radiation-induced mucositis.
Mantini G; Manfrida S; Cellini F; Giammarino D; Petrone A; Vitucci P; Cellini N
Rays; 2005; 30(2):137-44. PubMed ID: 16294906
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced cardiovascular disease: impact of dose and volume.
Mantini G; Smaniotto D; Balducci M; Dinapoli N; Campitelli M; Corvari B; Simili A; Ciarniello V
Rays; 2005; 30(2):157-68. PubMed ID: 16294909
[TBL] [Abstract][Full Text] [Related]
8. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
9. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526
[TBL] [Abstract][Full Text] [Related]
10. Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer.
Rojas AM; Lyn BE; Wilson EM; Williams FJ; Shah N; Dickson J; Saunders MI
Cancer; 2006 Sep; 107(6):1321-30. PubMed ID: 16902985
[TBL] [Abstract][Full Text] [Related]
11. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer.
van der Laan HP; van den Bergh A; Schilstra C; Vlasman R; Meertens H; Langendijk JA
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1138-45. PubMed ID: 17931794
[TBL] [Abstract][Full Text] [Related]
12. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance.
Liang SX; Zhu XD; Xu ZY; Zhu J; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):426-34. PubMed ID: 16690430
[TBL] [Abstract][Full Text] [Related]
13. Clinical and dosimetric predictors of acute toxicity after a 4-week hypofractionated external beam radiotherapy regimen for prostate cancer: results from a multicentric prospective trial.
Arcangeli S; Strigari L; Soete G; De Meerleer G; Gomellini S; Fonteyne V; Storme G; Arcangeli G
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):39-45. PubMed ID: 18538488
[TBL] [Abstract][Full Text] [Related]
14. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of life.
Dornfeld K; Simmons JR; Karnell L; Karnell M; Funk G; Yao M; Wacha J; Zimmerman B; Buatti JM
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):750-7. PubMed ID: 17418971
[TBL] [Abstract][Full Text] [Related]
15. Acute toxicity of conformal high dose interstitial brachytherapy boost in prostate cancer.
Soumarová R; Homola L; Stursa M; Perková H
Neoplasma; 2006; 53(5):410-7. PubMed ID: 17013535
[TBL] [Abstract][Full Text] [Related]
16. Measuring side effects after radiotherapy for pharynx cancer.
Jensen K
Acta Oncol; 2007; 46(8):1051-63. PubMed ID: 17882557
[TBL] [Abstract][Full Text] [Related]
17. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
[TBL] [Abstract][Full Text] [Related]
18. Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76 Gy?
Sanguineti G; Cavey ML; Endres EJ; Franzone P; Barra S; Parker BC; Marcenaro M; Colman M; Agostinelli S; Foppiano F; Vitale V
Strahlenther Onkol; 2006 Sep; 182(9):543-9. PubMed ID: 16944377
[TBL] [Abstract][Full Text] [Related]
19. Normal tissue tolerance dose metrics for radiation therapy of major organs.
Milano MT; Constine LS; Okunieff P
Semin Radiat Oncol; 2007 Apr; 17(2):131-40. PubMed ID: 17395043
[TBL] [Abstract][Full Text] [Related]
20. An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease.
Salama JK; Chmura SJ; Mehta N; Yenice KM; Stadler WM; Vokes EE; Haraf DJ; Hellman S; Weichselbaum RR
Clin Cancer Res; 2008 Aug; 14(16):5255-9. PubMed ID: 18698045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]